Conflict of Interest

Thompson D Understanding financial conflicts of interest N Engl J Med 1993329 573–57610.1056/NEJM199308193290812

Ramsey P The patient as person 1970 New Haven, CT Yale University Press

Beachamp TL Childress JF Principles of biomedical ethics 2001 5 New York, NY Oxford University Press

Barnes M Florencio P Financial conflicts of interest in human subjects research: the problem of institutional conflicts J Law Med Ethics 200230 1–1310.1111/j.1748-720X.2002.tb00408.x

Hillman AI Pauly MV Kerslein B How do financial incentives affect physician's clinical decisions and the financial performance of health maintenance organizations N Engl J Med 1989321 86–9210.1056/NEJM198907133210205

Hillman BJ Frequency and costs of diagnostic imaging in office practice: comparison of self-referring and radiologist referring physicians N Engl J Med 1990323 1604–160810.1056/NEJM199012063232306

Swerdlow A Increased costs and rates of use in the California workers’ compensation system as a result of self-referral by physicians N Engl J Med 1992327 1502–150610.1056/NEJM199211193272107

Wilkinson P (1993) Self-referral: a potential conflict of interest. Br Med J 1083–1084

Chren MM Landenfeld CS Physicians behavior and their interactions with drug companies: a controlled study of physicians who request additions to a hospital formulary JAMA 1994271 684–68910.1001/jama.271.9.684

Wazana A Physicians and the pharmaceutical industry: is a gift just ever a gift? JAMA 2000283 373–38010.1001/jama.283.3.373

Kassirer A piece of my mind: financial indigestion JAMA 2000284 2156–215710.1001/jama.284.17.2156

Rothman DJ Medical professionalism—focusing on the real issues NEJM 2000342 1284–128610.1056/NEJM200004273421711

Waud DR Pharmaceutical promotions—a free lunch NEJM 1992327 684–689

Andaleeb SS Tallman RF Physician attitudes toward pharmaceutical sales representatives Health Care Manage Rev 199520 68–76

Thomson AN Craig BJ Barham PM Attitudes of general practitioners in New Zealand to pharmaceutical representatives Br J Gen Pract 199444 220–223

Bekelman JE Li Y Gross CP Scope and impact of financial conflicts of interest in biomedical research JAMA 2003289 454–46510.1001/jama.289.4.454

Bayh–Dole Act, Pub L No. 96-517, 35 USC (1980)

Korn D Conflicts of interest in biomedical research JAMA 2000284 2234–223710.1001/jama.284.17.2234

Stolberg SG (1999) The biotech death of Jesse Gelsinger. New York Times Magazine, 28 Nov 1999

Beardsley T Gene therapy setback: a tragic death clouds the future of an innovative treatment method Sci Am 2000282 36–3710.1038/scientificamerican0200-36

Topol EJ Blumenthal D Physicians and the investment industry JAMA 2005293 2645–2657

Association of American Universities (2001) Task Force Report on Individual and Institutional Conflicts of Interest, Association of American Universities, Washington, DC, October, pp 1–22, at 10. Available at http://www.aau.edu/research/COI.01.pdf

Armstrong D (2005) The Wall Street Journal. 12 Dec 2005

International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Nov 2001: http://www.icmje.org

The Editors The Lancet's policy on conflicts of interest—2004 The Lancet 2004363 2–310.1016/S0140-6736(03)15229-4

The Editors Financial associations of authors NEJM 2002346 1901–190210.1056/NEJMe020074